```html

Wolff‑Parkinson‑White Syndrome (WPW) – A Complete Patient‑Friendly Guide

Overview

Wolff‑Parkinson‑White syndrome (WPW) is an abnormal electrical pathway in the heart that can cause episodes of rapid heart rate (tachycardia). The condition is present from birth (congenital) but often does not cause problems until adolescence or adulthood.

• Who it affects: Both males and females; slightly more common in males (≈55% of diagnosed cases).
• Prevalence: Occurs in about 1–3 per 1,000 people (0.1–0.3%). Approximately 0.25% of the general population carries the accessory pathway, but only ~1 in 10 of those develop symptoms.

WPW can be isolated or associated with other heart conditions such as congenital heart disease, hypertrophic cardiomyopathy, or genetic syndromes (e.g., PRKAG2 mutation). Most people live normal lives with appropriate management.

Sources: Mayo Clinic; CDC.

Symptoms

Symptoms vary widely—some people never notice anything, while others experience frequent palpitations. Below is a complete list with brief explanations.

Typical (most common) symptoms

• Palpitations: A sensation of a racing, fluttering, or pounding heartbeat.
• Rapid heart rate (tachycardia): Heart rates >150 beats per minute, often sudden in onset.
• Dizziness or light‑headedness: Caused by brief drops in blood pressure during fast rhythms.
• Shortness of breath: Especially during or after a tachycardia episode.
• Chest discomfort: Can feel like pressure or tightness; usually not angina but can be alarming.

Less common or atypical symptoms

• Syncope (fainting): Rare, usually when the rapid rhythm degenerates into a more dangerous arrhythmia.
• Fatigue or reduced exercise tolerance: Persistent rapid beats can wear the heart out.
• Heat intolerance or sweating: Autonomic response to sudden heart‑rate spikes.
• Anxiety or panic‑like feeling: Rapid heartbeats can trigger panic symptoms.

Asymptomatic presentation

Up to 70% of individuals with WPW are discovered incidentally on an electrocardiogram (ECG) performed for another reason.

Causes and Risk Factors

WPW is caused by an extra electrical connection called an accessory pathway (also known as the Bundle of Kent). This pathway allows electrical impulses to bypass the normal AV‑node delay, creating a shortcut that can lead to re‑entrant tachycardia.

Primary causes

• Congenital development: The accessory pathway forms during fetal heart development and persists after birth.
• Genetic predisposition: Mutations in genes such as PRKAG2 and HCM‑related genes have been linked to familial WPW.

Risk factors for symptomatic WPW

• Male sex (modestly higher incidence).
• Young age—symptoms often appear in teens or early 20s.
• Presence of structural heart disease (e.g., atrial septal defect, Ebstein anomaly).
• Family history of WPW or related arrhythmias.
• Use of certain stimulants (caffeine, nicotine, illicit drugs) that can trigger episodes.

Diagnosis

Diagnosing WPW involves a combination of clinical history, physical exam, and specific cardiac tests.

Electrocardiogram (ECG)

• Short PR interval (< 120 ms): Shows early conduction.
• Delta wave: Slurred upstroke of the QRS complex, hallmark of WPW.
• Widened QRS complex: Reflects the premature ventricular activation.

Holter monitor (24‑48 hour ambulatory ECG)

Detects intermittent tachyarrhythmias that may not appear on a single ECG.

Exercise stress test

Assesses how the heart responds to exertion; a sudden increase in heart rate may suggest an accessory pathway that conducts rapidly.

Electrophysiology (EP) study

Invasive test performed in a cardiac electrophysiology lab. Thin catheters are threaded into the heart to map electrical pathways, confirm the presence of an accessory pathway, and determine its exact location. This study is also therapeutic because it allows for immediate catheter ablation if indicated.

Imaging (Echocardiogram, Cardiac MRI)

Used mainly to rule out structural heart disease that may coexist with WPW.

Treatment Options

Treatment is individualized based on symptom severity, risk of sudden cardiac death, and patient preferences.

Medications

• Antiarrhythmic drugs:
  • Class IC (e.g., flecainide, propafenone) – effective in preventing AV‑reciprocal tachycardia but contraindicated in patients with structural heart disease.
  • Class III (e.g., ibutilide, amiodarone) – used for acute conversion of atrial fibrillation with WPW.
• Beta‑blockers or calcium‑channel blockers: Generally avoided in WPW when atrial fibrillation is a concern because they can preferentially block the AV node, allowing the accessory pathway to dominate and accelerate ventricular response.

Medication is usually a bridge to a definitive procedure or used when ablation is not feasible.

Catheter Ablation (Preferred Curative Therapy)

Radiofrequency (RF) or cryo‑ablation is performed via a catheter inserted through a vein (usually femoral). Energy is delivered to destroy the accessory pathway.

• Success rate >95% for a single procedure.
• Complication rate <1% (vascular injury, rare AV‑node damage).
• Most patients are discharged the same day or after an overnight stay.

Guidelines from the American College of Cardiology (ACC) and Heart Rhythm Society (HRS) recommend ablation as first‑line therapy for symptomatic WPW and for asymptomatic patients with high‑risk pathways (e.g., short refractory period).

Lifestyle Modifications

• Avoid excessive caffeine, alcohol, and recreational stimulants.
• Stay hydrated; dehydration can trigger tachycardia.
• Manage stress with relaxation techniques (deep breathing, yoga, CBT).
• Regular moderate exercise is encouraged unless a physician advises otherwise.

Living with Wolff‑Parkinson‑White Syndrome

With appropriate treatment, most people lead normal, active lives. Below are practical tips for day‑to‑day management.

Medication adherence

Take any prescribed antiarrhythmic exactly as directed. Keep a medication list handy for emergency personnel.

Regular follow‑up

Even after a successful ablation, a follow‑up ECG or Holter at 3‑6 months is recommended to confirm pathway elimination.

Know your triggers

Maintain a simple diary noting activities, foods, stress levels, and any episodes of palpitations. Patterns often emerge.

Emergency plan

• Carry a card that states “Wolff‑Parkinson‑White syndrome – avoid AV‑node blocking drugs unless authorized.”
• If you have a diagnosed accessory pathway and experience rapid, irregular heartbeat, call 911 immediately.

Fitness & recreation

Most patients can participate in sports, but certain high‑intensity or contact sports may need clearance from a cardiologist, especially if the pathway remains.

Pregnancy considerations

WPW does not usually affect fertility. During pregnancy, close monitoring is advised because hormonal changes can alter arrhythmia frequency. Ablation is generally deferred until after delivery unless refractory arrhythmias pose a serious risk.

Prevention

Because WPW is congenital, primary prevention of the condition itself isn’t possible. However, you can reduce the likelihood of symptomatic episodes and serious complications.

• Control modifiable triggers (caffeine, alcohol, illicit drugs).
• Maintain a heart‑healthy lifestyle: balanced diet, regular aerobic activity, adequate sleep.
• Promptly treat infections or fever, which can increase heart rate and precipitate tachycardia.
• If you have a family history of WPW, consider screening ECGs for close relatives.

Complications

Most people with WPW remain complication‑free, but untreated or high‑risk pathways can lead to serious outcomes.

• Atrioventricular re‑entrant tachycardia (AVRT): The most common arrhythmia, usually well tolerated but can cause syncope.
• Atrial fibrillation (AF) with rapid ventricular response: The accessory pathway can conduct impulses at rates >200 bpm, risking hemodynamic collapse.
• Sudden cardiac death (SCD): Rare (<0.1% per year) but linked to very fast‑conducting pathways or degeneration into ventricular fibrillation.
• Heart failure: Chronic tachycardia can lead to tachy‑cardiomyopathy, which is reversible after rate control or ablation.

Early identification and treatment, especially catheter ablation, dramatically lowers these risks.

When to Seek Emergency Care

References

1. Mayo Clinic. Wolff‑Parkinson‑White (WPW) syndrome. https://www.mayoclinic.org/diseases-conditions/wolff-parkinson-white-syndrome/symptoms-causes/syc-20354516 (accessed May 2026).
2. American Heart Association / American College of Cardiology. 2023 Guideline for the Management of Supraventricular Tachycardia. Circulation. 2023;148:e308‑e328.
3. Center for Disease Control and Prevention. Wolff–Parkinson–White syndrome. https://www.cdc.gov/heartdiseases/wpw.html (accessed May 2026).
4. HRS/EHRA Consensus Statement on Catheter Ablation of WPW. Heart Rhythm. 2022;19:1204‑1225.
5. NIH National Heart, Lung, and Blood Institute. Arrhythmias. https://www.nhlbi.nih.gov/health-topics/arrhythmia (accessed May 2026).
6. Cleveland Clinic. WPW Syndrome. https://my.clevelandclinic.org/health/diseases/17261-wolff-parkinson-white-syndrome (accessed May 2026).

```